Obesity and diabetes mellitus
DOI:
https://doi.org/10.47196/diab.v59i3Sup.1294Keywords:
obesity, diabetes mellitus, XX Graduate ConferenceAbstract
The Graduate School of the Argentine Diabetes Society (SAD) is a postgraduate program, and together with its Graduate Working Committee, comprised of its alumni, held its 20th Annual Conference, which focused on the topic of "Obesity and Diabetes."
The projected prevalence of diabetes mellitus (DM) in Central and South America by 2050 is 46%, while the global prevalence of overweight/obesity is estimated at 60%. This twin pandemic motivated the authors to present the topic discussed at one of the conference sessions: "Pharmacological and Surgical Therapies in Obesity and Diabetes."
Obesity and DM, so closely linked in their pathophysiology and treatment, prompted the authors to conduct a literature review with a high level of scientific evidence, resulting in an excellent publication that centers on the treatment of both diseases.
References
I. Comité de Graduados. Sociedad Argentina de Diabetes. Mesa 3: Terapéutica farmacológica y quirúrgica en obesidad y diabetes. Rev Soc Arg Diab 2025;59(sup3).
II. International Diabetes Federation. Diabetes Atlas. 11 th Edition. Disponible en: https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025-1.pdf.
III. Kimberly A, Gudzune M, Kushner MD Medications for obesity. A review JAMA 2024;332(7):571-584. doi:10.1001/jama.2024.10816.
IV. Drucker D. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diabetes Care 2024;47(00):1-16. doi: 10.2337/dci24-0003.
V. Cohen RV, Busetto L, Levinson R, et al.; 3 on behalf of the experts of the International Consensus on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery. International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Br J Surg 2024;111(12). doi: 10.1093/bjs/znae283.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
